Lohse, DE
Andrea Lohse, Bottrop DE
Patent application number | Description | Published |
---|---|---|
20080216708 | Organically modified siloxanes and their use for producing preparations for water-repellent impregnations - The invention relates to organomodified siloxane compounds of the general formula (I) | 09-11-2008 |
20090007483 | Organofunctionally modified polysiloxanes and use thereof for defoaming liquid fuels with biofuel additions - The invention relates to organofunctionally modified polysiloxanes and to their use for defoaming liquid fuels, especially diesel fuels and diesel fuels to which biofuels have been added. | 01-08-2009 |
20100081763 | EMULSIFIER SYSTEMS FOR COSMETIC AND PHARMACEUTICAL OIL-IN-WATER EMULSIONS - The invention relates to emulsifier systems for cosmetic and pharmaceutical oil-in-water emulsions comprising high molecular weight organomodified polysiloxanes with a dispersion index greater than 1.6. | 04-01-2010 |
20110091399 | USE OF ORGANO-MODIFIED SILOXANE BLOCK COPOLYMERS FOR PRODUCING COSMETIC OR PHARMACEUTICAL COMPOSITIONS - The invention relates to emulsifier systems comprising organomodified siloxane block copolymers, their use, in particular the preparation of cosmetic, dermatological or pharmaceutical formulations, and of care and cleaning compositions, and also the products themselves prepared with the help of emulsifier systems. | 04-21-2011 |
20130040875 | PROCESS FOR PRODUCING POLYSILOXANES WITH NITROGEN-CONTAINING GROUPS - A process for producing amino-functional polysiloxanes by reacting the components A) identical or different terminally hydroxy-functional, linear or branched polysiloxanes, B) identical or different alkoxysilanes of the formula | 02-14-2013 |
Ansgar Lohse, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20140294982 | NANOPARTICLE COMPOSITIONS FOR GENERATION OF REGULATORY T CELLS AND TREATMENT OF AUTOIMMUNE DISEASES AND OTHER CHRONIC INFLAMMATORY CONDITIONS - The present invention relates to nanoparticles for the targeted delivery of antigen to liver cells, in particular, liver sinusoidal endothelial cells (LSEC) and/or Kupffer cells, and for the in vivo generation of regulatory T cells, notably CD4+CD25+FOXP3+ regulatory T cells (Treg). The invention provides pharmaceutical compositions and methods for the prevention and treatment of autoimmune diseases, allergies or other chronic inflammatory conditions, and for generation of regulatory T cells. The nanoparticles used in the invention comprise a) a micelle comprising an amphiphilic polymer rendering the nanoparticle water-soluble, and b) a peptide comprising at least one T cell epitope associated with the outside of the micelle. The micelle may or may not comprise a solid hydrophobic core. | 10-02-2014 |
Ansgar W. Lohse, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20140329758 | PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSES - The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides. | 11-06-2014 |
20150297693 | PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSES - The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides. | 10-22-2015 |
Ansgar W. Lohse, Mainz DE
Patent application number | Description | Published |
---|---|---|
20080267983 | Peptide Inhibitors for Mediating Stress Responses - The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing peptides recognized by monoclonal anti-DNA antibodies, the peptides having anti-apoptotic and anti-inflammatory activity. The invention further provides antibody molecules and uses thereof for the isolation of such peptides. | 10-30-2008 |
20120171233 | PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSES - The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides. | 07-05-2012 |
Enno Lohse, Stolberg DE
Patent application number | Description | Published |
---|---|---|
20100294246 | PARALLEL CRANK DRIVE - The invention relates to a parallel crank drive ( | 11-25-2010 |
Erik Lohse, Hoisdorf DE
Patent application number | Description | Published |
---|---|---|
20130044209 | APPARATUS AND METHOD FOR DETECTING THE SURFACE DEFECT OF THE GLASS SUBSTRATE - The apparatus for detecting surface defects of a glass substrate, having a dark field optical system, includes: a first photographing device for photographing first image; a second photographing for photographing second image; a dark field illumination system disposed below the glass substrate for serving as a dark field illumination; and a detection signal processor operating coordinates of a defect position on the first image and the second image, wherein the first photographing device and the second photographing device form photographing areas in the shape of lines which are not parallel to at least the transferring direction of the glass substrate, form photographing areas for a top surface of the glass substrate to be overlapped by each other and form photographing areas for a bottom surface of the glass substrate differently from each other. | 02-21-2013 |
Florian Lohse, Berlin DE
Patent application number | Description | Published |
---|---|---|
20150118941 | METHOD AND APPARATUS FOR SHORTENING THE ROTOR BLADES OF A TURBOMACHINE - A method for shortening one or more rotor blade(s) ( | 04-30-2015 |
Jakob Lohse, Berlin DE
Jirko Lohse, Dresden DE
Patent application number | Description | Published |
---|---|---|
20150280276 | Battery, a Battery Element and a Method for Forming a Battery - A battery includes at least two externally accessible battery electrodes to provide a supply voltage and at least more than half of a wafer including at least two wafer electrodes. The wafer includes a plurality of trenches reaching into the wafer. At least a part of a trench of the plurality of trenches is filled with a solid state battery structure. The solid state battery structure within the trench includes electrodes electrically connected to the wafer electrodes. | 10-01-2015 |
Karsten Lohse, Wuertburg DE
Patent application number | Description | Published |
---|---|---|
20100019710 | Method and device for determining the position of a rotor of a brushless and sensorless electric motor - The invention relates to a method carried out with simple means for determining the position of the rotor in a sensorless and brushless multi-phase electric motor ( | 01-28-2010 |
Manuela Lohse, Jena DE
Patent application number | Description | Published |
---|---|---|
20110090492 | Method of evaluating defects in a material transparent to electromagnetic radiation, especially for optical applications, apparatus for performing said method, and materials selected thereby - The method of evaluating an optical defect in a transparent material includes irradiating the material with light to produce scattered light from the defect, rotating the material about a rotation axis passing through the defect, measuring scattered light intensity at a scattering angle (θ | 04-21-2011 |
Martin Lohse, Gauting DE
Patent application number | Description | Published |
---|---|---|
20080294838 | UNIVERSAL BOOT LOADER USING PROGRAMMABLE ON-CHIP NON-VOLATILE MEMORY - In one embodiment, an IC system includes a system on a chip (SoC) adapted to load boot-up code from an external NAND flash memory, which stores the boot-up code. The SoC has a processor, an internal ROM including boot-loading code, an operating RAM, a NAND flash controller (NFC), and an OTP memory. At some point after SoC manufacture, the OTP memory is programmed with parameters needed for communication between the NFC and the external NAND flash memory. This provides a system designer flexibility in choosing a type of external NAND flash memory for the IC system. During SoC power-up, the NFC is initialized with the communication parameters, thereby allowing the NFC to control the NAND flash memory. The boot-loading code directs the processor to load the boot-up code from the external NAND memory onto the operating RAM. The processor then executes the boot-up code from the operating RAM. | 11-27-2008 |
20090113166 | HASHING METHOD FOR NAND FLASH MEMORY - In accordance with exemplary embodiments, a flash memory, such as a NAND flash memory, selectively updates blocks based on hash values associated with the blocks, wherein the hashing codes are generated for each block from the software image to be programmed into the flash memory. Selectively updating blocks in accordance with an embodiment of the present invention might reduce re-programming time and potentially destructive pre-mature aging of cells in the flash memory. | 04-30-2009 |
Martin Lohse, Wurzburg DE
Patent application number | Description | Published |
---|---|---|
20150038673 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES - The present invention relates to novel β-AR homologous cyclopeptide-mutants comprising only two cysteine residues able to form an intramolecular linkage, to linear peptides that can form these cyclopeptide-mutants and to nucleic acid molecules encoding these cyclopeptide-mutants and linear peptides. Moreover, vectors and recombinant host cells comprising said nucleic acid molecule and a method for producing the disclosed cyclopeptide-mutants are provided. Further provided is a composition comprising the peptides, nucleic acid molecules, vectors or host cells of the invention. The present invention also relates to therapeutic and diagnostic means, methods and uses taking advantage of the peptides of the invention and to means, methods and uses for detecting anti-.beta.-adrenergic receptor antibodies like anti-β | 02-05-2015 |
Martin A. Lohse, Munich DE
Patent application number | Description | Published |
---|---|---|
20090296485 | DIFFERENTIAL FLASH MEMORY PROGRAMMING TECHNIQUE - The invention relates flash memory programming techniques. An object of the invention is to provide a flash memory programming technique avoiding problems of the known state of the art and in particular, saving a significant amount of time during the development and/or production phases of any equipment containing flash memory devices and also saving time during an updating or upgrading procedure of such an equipment already being in use. Accordingly, the invention proposes for programming a flash memory device to program only differences in information between data already stored in the flash memory device and new data to be stored. | 12-03-2009 |
Martin J. Lohse, Wuerzburg DE
Patent application number | Description | Published |
---|---|---|
20110274694 | ERK1/2 Posphorylation Site Specific Antibody - The invention relates to an antibody specific to Erk1/2 phosphorylated at Thr188 and a method for producing the same. The invention also relates to an in vitro method for determining the presence of phosphorylated Erk1/2 in a sample using the antibody of the invention. Therefore, the invention also comprises an assay for diagnosing a heart disease in vitro comprising the antibody of the invention and certain uses of the antibody. Moreover the invention relates to a peptide used to produce the antibody. | 11-10-2011 |
Martin J. Lohse, Würzburg DE
Patent application number | Description | Published |
---|---|---|
20080286760 | Means and Methods for the Determination of Camp In Vitro and In Vivo - The present invention relates to a chimeric peptide, comprising a cAMP binding moiety having only one cAMP binding site and at least two detectable labels, whereby the first of said two detectable labels is located at the carboxy terminus and the second of said two detectable labels is located at the amino terminus of said cAMP binding moiety. Said chimeric peptide of the invention is particularly useful in/for direct determination of cAMP concentrations) in vitro and/or in vivo. Furthermore, nucleic acid molecules encoding said chimeric proteins are described as well as vectors and host cells comprising the same. The present invention also provides methods for producing the chimeric protein of the invention and methods for identification and screening of molecules or compounds which are capable of modifying cAMP binding to the chimeric peptide of the invention or the biological and/or pharmacological function of adenylyl cyclases or phosphodiesterases. In addition, a method for cAMP determination in a sample and a method for the detection of cAMP in the living cell or tissue is described. Finally, a kit comprising the compounds of the present invention is disclosed. | 11-20-2008 |
20090215675 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - The present invention is related to a peptide selected from the group comprising a) a cyclic peptide of formula (I): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-x-x-x-Pro-x-Cys-Cys-xk-GIn), (I) whereby k is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably k=6; b) a cyclic peptide of formula (II): Cyclo(Ala-x-x-Trp-x-x-Gly-x-Phe-x-Cys-xh-Gln), (II) whereby h is any integer from 0 to 2, preferably 1 or 2; c) a cyclic peptide of formula (III): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-xj-Cys-x-x-x-Pro-x-Cys-Cys-xi-Gln); (HI) whereby j is any integer from 0 to 4, preferably j=4; whereby i is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably i−6; and d) a peptide of formula (IV): Ala-x1-Cys-xm-Cys-x-x-x-Pro-x-Cys-Cys-xn-Gln, (IV) whereby 1 is any integer from 0 to 9, preferably any integer from 1 to 9, more preferably n=9; whereby m is any integer from 0 to 4, preferably any integer from 1 to 4, more preferably m=4; whereby n is any integer from O to 6, preferably any integer from 1 to 6, more preferably n=6; whereby x is any amino acid, preferably any naturally occurring amino acid, more preferably any naturally occurring L-amino acid. | 08-27-2009 |
Martin J. Lohse, Wurzburg DE
Patent application number | Description | Published |
---|---|---|
20080286760 | Means and Methods for the Determination of Camp In Vitro and In Vivo - The present invention relates to a chimeric peptide, comprising a cAMP binding moiety having only one cAMP binding site and at least two detectable labels, whereby the first of said two detectable labels is located at the carboxy terminus and the second of said two detectable labels is located at the amino terminus of said cAMP binding moiety. Said chimeric peptide of the invention is particularly useful in/for direct determination of cAMP concentrations) in vitro and/or in vivo. Furthermore, nucleic acid molecules encoding said chimeric proteins are described as well as vectors and host cells comprising the same. The present invention also provides methods for producing the chimeric protein of the invention and methods for identification and screening of molecules or compounds which are capable of modifying cAMP binding to the chimeric peptide of the invention or the biological and/or pharmacological function of adenylyl cyclases or phosphodiesterases. In addition, a method for cAMP determination in a sample and a method for the detection of cAMP in the living cell or tissue is described. Finally, a kit comprising the compounds of the present invention is disclosed. | 11-20-2008 |
20090215675 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - The present invention is related to a peptide selected from the group comprising a) a cyclic peptide of formula (I): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-x-x-x-Pro-x-Cys-Cys-xk-GIn), (I) whereby k is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably k=6; b) a cyclic peptide of formula (II): Cyclo(Ala-x-x-Trp-x-x-Gly-x-Phe-x-Cys-xh-Gln), (II) whereby h is any integer from 0 to 2, preferably 1 or 2; c) a cyclic peptide of formula (III): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-xj-Cys-x-x-x-Pro-x-Cys-Cys-xi-Gln); (HI) whereby j is any integer from 0 to 4, preferably j=4; whereby i is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably i−6; and d) a peptide of formula (IV): Ala-x1-Cys-xm-Cys-x-x-x-Pro-x-Cys-Cys-xn-Gln, (IV) whereby 1 is any integer from 0 to 9, preferably any integer from 1 to 9, more preferably n=9; whereby m is any integer from 0 to 4, preferably any integer from 1 to 4, more preferably m=4; whereby n is any integer from O to 6, preferably any integer from 1 to 6, more preferably n=6; whereby x is any amino acid, preferably any naturally occurring amino acid, more preferably any naturally occurring L-amino acid. | 08-27-2009 |
20100209445 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES - The present invention relates to novel β-AR homologous cyclopeptide-mutants comprising only two cysteine residues able to form an intramolecular linkage, to linear peptides that can form these cyclopeptide-mutants and to nucleic acid molecules encoding these cyclopeptide-mutants and linear peptides. Moreover, vectors and recombinant host cells comprising said nucleic acid molecule and a method for producing the disclosed cyclopeptide-mutants are provided. Further provided is a composition comprising the peptides, nucleic acid molecules, vectors or host cells of the invention. The present invention also relates to therapeutic and diagnostic means, methods and uses taking advantage of the peptides of the invention and to means, methods and uses for detecting anti-β-adrenergic receptor antibodies like anti-βradrenergic receptor antibodies. | 08-19-2010 |
20120288513 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - Embodiments of the present invention provide for novel peptides of use for detection and/or inhibition of anti-β1-adrenergic receptor antibodies. Certain embodiments concern uses of cyclic and/or linear peptides. In other embodiments, the present invention relates to novel peptides of use in diagnostic and/or pharmaceutical compositions. Some embodiments concern diagnosing and/or treating cardiac conditions. Cardiac conditions of the instant invention can concern infectious heart disease, non-infectious heart disease, ischemic heart disease, non-ischemic heart disease, inflammatory heart disease, myocarditis, cardiac dilatation, idiopathic cardiomyopathy, idiopathic dilated cardiomyopathy, immune-cardiomyopathy, heart failure, and any cardiac arrhythmia condition. | 11-15-2012 |
20120288870 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - Embodiments of the present invention provide for novel peptides of use for detection and/or inhibition of anti-β1-adrenergic receptor antibodies. Certain embodiments concern uses of cyclic and/or linear peptides. In other embodiments, the present invention relates to novel peptides of use in diagnostic and/or pharmaceutical compositions. Some embodiments concern diagnosing and/or treating cardiac conditions. Cardiac conditions of the instant invention can concern infectious heart disease, non-infectious heart disease, ischemic heart disease, non-ischemic heart disease, inflammatory heart disease, myocarditis, cardiac dilatation, idiopathic cardiomyopathy, idiopathic dilated cardiomyopathy, immune-cardiomyopathy, heart failure, and any cardiac arrhythmia condition. | 11-15-2012 |
Martin J. Lohse, Wfuzburg DE
Patent application number | Description | Published |
---|---|---|
20140273015 | BINDING COMPOUNDS TO HUMAN Beta 1-ADRENORECEPTOR (Beta 1-AR) AND THEIR USE IN MEASUREMENT OF AUTO-ANTI- Beta 1-AR ANTIBODIES - The present disclosure relates to binding compounds/antibodies that bind to the second extracellular loop of the human β1-adrenoreceptor (β1-AR-ECII) that are produced by/obtainable from a host cell/hybridoma with a deposit number selected from the group consisting of DSM ACC3121, DSM ACC3174, DSM ACC3175, DSM ACC3176 and DSM AC-C3177. The binding compounds/antibodies are particularly useful in determination of auto-anti-β1-AR antibodies in an in vitro cell based assay system in order to characterize and to identify auto-antibodies directed against the β1-AR-ECII in a biological sample. Further aspects of the disclosure are nucleic acid molecules encoding said binding compounds/antibodies, vectors, host cells, methods for producing the binding compounds/antibodies of the disclosure as well as a kit comprising the binding compounds/antibodies of the present disclosure. | 09-18-2014 |
Michael Lohse, Goslar DE
Patent application number | Description | Published |
---|---|---|
20100028250 | METHOD FOR PRODUCTION OFAMMONIUM PARATUNGSTATE TETRAHYDRATE AND HIGHLY PURE AMMONIUM PARATUNGSTATE TETRAHYDRATE - The invention is directed to a method for the production of ammonium paratungstate tetrahydrate by thermal treatment of ammonium paratungstate decahydrate in an aqueous suspension. The ammonium paratungstate tetrahydrate can be produced with high purity and high yield. The production method may furthermore be carried out in a simple and energy-efficient manner. | 02-04-2010 |
20100098619 | METHOD FOR PRODUCING AMMONIUM PARATUNGSTATE HYDRATES AND AMMONIUM PARATUNGSTATE DECAHYDRATE - The invention is directed to a process for the continuous preparation of ammonium paratungstate hydrate by back reextraction of a tungsten-laden organic phase with an ammonia-containing aqueous solution in a mixer-settler apparatus. The reextraction is carried out at an NH | 04-22-2010 |
20110070148 | METHOD FOR PRODUCTION OF AMMONIUM PARATUNGSTATE TETRAHYDRATE AND HIGHLY PURE AMMONIUM PARATUNGSTATE TETRAHYDRATE - The invention is directed to a method for the production of ammonium paratungstate tetrahydrate by thermal treatment of ammonium paratungstate decahydrate in an aqueous suspension. The ammonium paratungstate tetrahydrate can be produced with high purity and high yield. The production method may furthermore be carried out in a simple and energy-efficient manner. | 03-24-2011 |
20130029153 | AMMONIUM PARATUNGSTATE HYDRATES AND AMMONIUM PARATUNGSTATE DECAHYDRATE - The invention is directed to ammonium paratungstate decahydrate containing at least 75% of crystals having a length of at least 200 μm and having a ratio of length to width of less than 4.5:1. | 01-31-2013 |
Rieke Lohse, Biefeld DE
Patent application number | Description | Published |
---|---|---|
20160113289 | SPRAY FORMULATION AND ITS USE IN PLANT PROTECTION - The present invention relates in a first aspect to a spray formulation. In particular, said spray formulation is a spray formulation adapted for colonisation of plants with spores of endophytes, in particular, entomopathogenic endophytes. The spray formulation according to the present invention includes a surfactant, an UV-protecting compound, a nutrient and spores of the endophytes. In another aspect, the present invention relates to the use of said spray formulation in plant protection, in particular, crop plant protection, and control of plant pests and plant pathogens. Moreover, a method of preventing or treating infestation of plants with plant pests or plant pathogens, is provided comprising the step of applying a spray formulation according to the present invention onto the plants or a part of the plants. Finally, a kit is provided comprising spores of endophytes and a spray formulation as defined herein. | 04-28-2016 |
Thomas Lohse, Dresden DE
Patent application number | Description | Published |
---|---|---|
20130026379 | DIRECT CONVERSION X-RAY DETECTOR WITH RADIATION PROTECTION FOR ELECTRONICS - The present invention relates to an X-ray detector having an X-ray sensor (first X-ray sensor) converting X-radiation directly into electric charge carriers, having signal evaluation electronics electrically connected to the X-ray sensor and preferably formed as integrated circuit(s), having an X-ray absorber formed for protecting the signal evaluation electronics, and having a sensor carrier (first sensor carrier) formed and arranged for positioning the X-ray sensor relative to the X-ray absorber, wherein, viewed in the direction of incidence of the X-radiation, both the signal evaluation electronics are arranged behind the X-ray absorber and in the X-radiation shadow thereof and the X-ray sensor is admittedly likewise positioned by means of the sensor carrier preferably arranged between the X-ray absorber and the signal evaluation electronics at least sectionally behind the X-ray absorber, but outside the X-radiation shadow thereof. | 01-31-2013 |
Udo Lohse, Strassenhaus DE
Patent application number | Description | Published |
---|---|---|
20130322963 | ROTOR HOOD FOR A MILLING APPARATUS - The present invention relates to a rotor hood for a milling apparatus, with a front hood part, a rear hood part and two side hood parts, the front and the rear hood part enclosing together with the two side hood parts a working space that is open at the bottom, further comprising a stripping device which is mounted on the rotor hood and which forms the rear lower edge of the rotor hood in the working direction. The present invention further relates to a construction machine with a milling apparatus and such a rotor hood and a method for operating a milling apparatus with a rotor hood. | 12-05-2013 |
Uwe Lohse, Freiberg DE
Patent application number | Description | Published |
---|---|---|
20120061277 | STORAGE AND TRANSPORT CONTAINER - Provided is a stackable storage and transport container for storing and for single-use or multiple-use transport of goods, especially small parts.The container is assembled from a foldable container blank having a bottom, two side walls foldable about a fold, two end walls foldable about a fold, and four corner flaps foldable inward against the side walls or end walls about a fold. Tabs are formed on the side walls and end walls such that they can fold laterally against the intermediate pieces. A stackable profile having a hook edge is placed about the upper edge to provide for the stacking of a number of containers. The container blank preferably is made of a plastic hollow sheet. | 03-15-2012 |
Uwe Lohse, Remscheid DE
Patent application number | Description | Published |
---|---|---|
20110214431 | TURBINE GUIDE VANE SUPPORT FOR A GAS TURBINE AND METHOD FOR OPERATING A GAS TURBINE - A turbine guide vane support for an axial-flow gas turbine is provided. The support includes a tubular wall having an inflow-side end and an outflow-side end for a hot gas flowing in the interior of the turbine guide vane support in a flow path of the gas turbine. Cooling channels for a coolant are provided in the wall. The cooling channels extend from a coolant inlet to a coolant outlet, respectively. At least one of the cooling inlets and one of the cooling outlets, respectively, is disposed at the outflow-side end of the turbine guide vane support, wherein the cooling channel associated with the respective inlet and outlet extends up to the inflow-side end of the turbine guide vane support and transitions to a redirecting area from which the respective cooling channel further extends to the outflow-side end. | 09-08-2011 |
20120017594 | SEAL ASSEMBLY FOR CONTROLLING FLUID FLOW - A seal assembly ( | 01-26-2012 |
20140147258 | HYDRAULIC BEARING FOR A STATIONARY GAS TURBINE - A hydraulic bearing is provided for a stationary gas turbine that has an oil sump with an outflow for hydraulic oil, wherein the outflow has an outflow opening which is arranged in the oil sump and an outflow line which is connected to the outflow opening. The hydraulic bearing is adapted to bring about an annular flow with a central air column when hydraulic oil flows out in the outflow line. | 05-29-2014 |
20140301820 | TURBINE ENGINE SHUTDOWN TEMPERATURE CONTROL SYSTEM WITH NOZZLE INJECTION FOR A GAS TURBINE ENGINE - A turbine engine shutdown temperature control system configured to limit thermal gradients from being created within an outer casing surrounding a turbine blade assembly during shutdown of a gas turbine engine is disclosed. By reducing thermal gradients caused by hot air buoyancy within the mid-region cavities in the outer casing, arched and sway-back bending of the outer casing is prevented, thereby reducing the likelihood of blade tip rub, and potential blade damage, during a warm restart of the gas turbine engine. The turbine engine shutdown temperature control system may operate during the shutdown process where the rotor is still powered by combustion gases or during turning gear system operation after shutdown of the gas turbine engine, or both, to allow the outer casing to uniformly, from top to bottom, cool down. | 10-09-2014 |